Vinayak Singh

25PUBLICATIONS
57CO-AUTHORS
Biomolecular modelling and designGene and molecular therapyMycologyNanotoxicology, health and safetyMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|May 27, 2026
Development of Isoniazid-Pyrazole Hybrids as Potential Antitubercular Agents.

|Jan 15, 2025
The next generation of drug resistant tuberculosis drug design.

Vinayak Singh

|Jan 31, 2024
Unlocking Opportunities for Mycobacterium leprae and Mycobacterium ulcerans.

Mousumi Shyam, Sumit Kumar, Vinayak Singh

|May 01, 2023
Recent developments of imidazo[1,2-a]pyridine analogues as antituberculosis agents.

Sauvik Samanta, Sumit Kumar, Eswar K Aratikatla

|Apr 28, 2023
The implication of Mycobacterium tuberculosis-mediated metabolism of targeted xenobiotics.

Vinayak Singh, Godwin Akpeko Dziwornu, Kelly Chibale

|Nov 03, 2022
1,3-Diarylpyrazolyl-acylsulfonamides Target HadAB/BC Complex in Mycobacterium tuberculosis.

Vinayak Singh, Anna E Grzegorzewicz, Stephen Fienberg

Pageof 5

Frequent Collaborators

11 joint publications

Kelly Chibale

5 joint publications

Sandeep R Ghorpade

4 joint publications

Helena I M Boshoff

4 joint publications

Gregory S Basarab